Noven Pharma

Noven Pharmaceuticals is a specialty pharmaceutical company that excels in the development and manufacturing of transdermal drug delivery systems. As a stand-alone subsidiary of Hisamitsu Pharmaceutical, Noven leverages its proprietary DOT Matrix technology to produce thin, multi-polymer patches that offer controlled drug release. The company's commercial portfolio is primarily focused on women's health, specifically hormone replacement therapies, and central nervous system disorders such as ADHD and schizophrenia. Noven maintains a fully integrated operation in Miami, Florida, encompassing research, development, and large-scale GMP manufacturing. Their expertise in adhesive chemistry and patch design has made them a key player in the global transdermal market.